How do we Ensure Appropriate Access to the COVID-19 Vaccine and Ensure Success for this Unprecedented Public Health Challenge? An interesting commentary in The Lancet published December 10, 2020 by Peter Hotez and Walter Orenstein looks at this issue. They offer a...
An interesting article published in emerging infectious diseases volume 27, number 1, January 2021 by Galle and others investigated this issue. They investigated SARS-CoV-2 specific antibodies and T-cell responses against SARS-CoV-2 in 11 SARS-CoV-2 serodiscordant...
Many patients who under normal circumstances would have been admitted to hospital, manage their own extremely difficult circumstances at home during the crisis. How do we deal with its effects following COVID-19? Following the active rehabilitation from the start,...
An interesting preprint by Cirulli and Others in medRxiv looks at this important issue. It has become increasingly apparent that a subset of infected individuals develop long term complications following SARS-CoV-2 infection. Doctors continue to report their...
An editorial in The Lancet dated December 4, 2020 looks at this important issue. There are now several COVID-19 vaccine candidates that seem to be at least 90% efficacious. This was clearly received with much enthusiasm and unquestionable relief. There is a challenge...
A recent article published in the British Medical Journal dated 7 October 2020 looked at this issue. Rapid diagnostic tests are integral to the government’s Moonshot plan to carry out up to 10 million COVID-19 tests a day by early 2021. Jacqui Wise published her...
